Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Smooth muscle tumors of the gastrointestinal tract: an analysis of prognostic features in 407 cases.

Alpert L, Al-Sabti R, Graham RP, Pai RK, Gonzalez RS, Zhang X, Smith V, Wang HL, Westbrook L, Goldblum JR, Bakhshwin A, Shetty S, Klimstra DS, Shia J, Askan G, Robert ME, Thomas C, Frankel WL, Alsomali M, Hagen C, Mostafa ME, Feely MM, Assarzadegan N, Misdraji J, Shih AR, Agostini-Vulaj D, Meis JM, Tang S, Chatterjee D, Kang LI, Hart J, Lee SM, Smith T, Yantiss RK, Hissong EM, Gao ZH, Wu J, Resnick MB, Wu EY, Pai RK, Zhao L, Doyle LA, Chopra S, Panarelli NC, Hu S, Longacre TA, Raghavan SS, Lauwers GY, Ghayouri M, Cooper HS, Nagarathinam R, Bellizzi AM, Kakar S, Hosseini M, Rong J, Greenson JK, Lamps LW, Dong Z, Bronner MP.

Mod Pathol. 2020 Feb 12. doi: 10.1038/s41379-020-0492-5. [Epub ahead of print]

PMID:
32051556
2.

Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance.

Lu S, Yakirevich E, Wang LJ, Resnick MB, Wang Y.

BMC Cancer. 2019 Nov 12;19(1):1085. doi: 10.1186/s12885-019-6295-8.

3.

Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer.

Zhao CL, Singh K, Brodsky AS, Lu S, Graves TA, Fenton MA, Yang D, Sturtevant A, Resnick MB, Wang Y.

BMC Cancer. 2019 Nov 1;19(1):1036. doi: 10.1186/s12885-019-6134-y.

4.

TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations.

Ouseph MM, Taber A, Khurshid H, Madison R, Aswad BI, Resnick MB, Yakirevich E, Ali SM, Patel NR.

Lung Cancer (Auckl). 2019 Aug 15;10:81-86. doi: 10.2147/LCTT.S212406. eCollection 2019.

5.

Retrospective Analysis Confirms Tetracycline Quadruple as Best Helicobacter pylori Regimen in the USA.

Alsamman MA, Vecchio EC, Shawwa K, Acosta-Gonzales G, Resnick MB, Moss SF.

Dig Dis Sci. 2019 Oct;64(10):2893-2898. doi: 10.1007/s10620-019-05694-4. Epub 2019 Jun 11.

PMID:
31187323
6.

Expression of Indoleamine 2, 3-dioxygenase 1 (IDO1) and Tryptophanyl-tRNA Synthetase (WARS) in Gastric Cancer Molecular Subtypes.

Lu S, Wang LJ, Lombardo K, Kwak Y, Kim WH, Resnick MB.

Appl Immunohistochem Mol Morphol. 2019 Apr 24. doi: 10.1097/PAI.0000000000000761. [Epub ahead of print]

PMID:
31033497
7.

In reply to Lambein et al.: 'HER2 protein overexpression in non-amplified ductal carcinoma in situ: quality issue or transcription mechanisms gone awry?'

Wang Y, Hui Y, Resnick MB.

Histopathology. 2019 Mar;74(4):666. doi: 10.1111/his.13792. Epub 2019 Jan 15. No abstract available.

PMID:
30447011
8.

ColXα1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix.

Wang Y, Lu S, Xiong J, Singh K, Hui Y, Zhao C, Brodsky AS, Yang D, Jolly G, Ouseph M, Schorl C, DeLellis RA, Resnick MB.

J Pathol Clin Res. 2019 Jan;5(1):40-52. doi: 10.1002/cjp2.115. Epub 2018 Nov 1.

9.

Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression.

Acosta-Gonzalez G, Ouseph M, Lombardo K, Lu S, Glickman J, Resnick MB.

Hum Pathol. 2019 Jan;83:115-123. doi: 10.1016/j.humpath.2018.08.020. Epub 2018 Aug 31.

10.

Discordant HER2 immunohistochemical expression and gene amplification in ductal carcinoma in situ - evaluating HER2 in synchronous in-situ and invasive carcinoma.

Hui Y, Lu S, Wang H, Resnick MB, Wang Y.

Histopathology. 2019 Jan;74(2):358-362. doi: 10.1111/his.13731. Epub 2018 Oct 29. No abstract available.

PMID:
30117181
11.

Differentiating breast carcinoma with signet ring features from gastrointestinal signet ring carcinoma: assessment of immunohistochemical markers.

Hui Y, Wang Y, Nam G, Fanion J, Sturtevant A, Lombardo KA, Resnick MB.

Hum Pathol. 2018 Jul;77:11-19. doi: 10.1016/j.humpath.2018.01.002. Epub 2018 Jan 6.

12.

Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.

Wang Y, Brodsky AS, Xiong J, Lopresti ML, Yang D, Resnick MB.

Clin Breast Cancer. 2018 Jun;18(3):e373-e379. doi: 10.1016/j.clbc.2017.08.007. Epub 2017 Aug 19.

PMID:
28890185
13.

Clinicopathologic and gene expression analysis of initial biopsies from patients with eosinophilic esophagitis refractory to therapy.

Siddique AS, Corney DC, Mangray S, Lombardo KA, Chen S, Marwaha AS, Resnick MB, Herzlinger M, Matoso A.

Hum Pathol. 2017 Oct;68:79-86. doi: 10.1016/j.humpath.2017.08.027. Epub 2017 Sep 4.

PMID:
28882697
14.

Role of immune microenvironment in gastrointestinal stromal tumours.

Blakely AM, Matoso A, Patil PA, Taliano R, Machan JT, Miner TJ, Lombardo KA, Resnick MB, Wang LJ.

Histopathology. 2018 Feb;72(3):405-413. doi: 10.1111/his.13382. Epub 2017 Nov 21.

PMID:
28871595
15.

ALOX15 Immunohistochemistry Aids in the Diagnosis of Eosinophilic Esophagitis on Pauci-eosinophilic Biopsies in Children.

Hui Y, Chen S, Lombardo KA, Resnick MB, Mangray S, Matoso A.

Pediatr Dev Pathol. 2017 Sep-Oct;20(5):375-380. doi: 10.1177/1093526617693106. Epub 2017 Feb 9.

PMID:
28812459
16.

Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma.

Yakirevich E, Lu S, Allen D, Mangray S, Fanion JR, Lombardo KA, Safran H, Resnick MB.

Hum Pathol. 2017 Aug;66:126-135. doi: 10.1016/j.humpath.2017.06.009. Epub 2017 Jun 28.

PMID:
28666927
17.

Human Papillomavirus Genotyping of Incidental Malignant and Premalignant Lesions on Hemorrhoidectomy Specimens.

Hui Y, Quddus MR, Murthy JN, Yang D, Sung CJ, Lu S, Resnick MB, Wang LJ.

Am J Surg Pathol. 2017 Mar;41(3):382-388. doi: 10.1097/PAS.0000000000000809.

PMID:
28098569
18.

The Inflammatory Milieu of Eosinophilic Esophagitis: A Contemporary Review With Emphasis in Putative Immunohistochemistry and Serologic Markers.

Lepe M, O'Connell D, Lombardo KA, Herzlinger M, Mangray S, Resnick MB, Matoso A.

Appl Immunohistochem Mol Morphol. 2018 Aug;26(7):435-444. doi: 10.1097/PAI.0000000000000450. Review.

PMID:
27801733
19.

Collagen type III α1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast.

Wang Y, Resnick MB, Lu S, Hui Y, Brodsky AS, Yang D, Yakirevich E, Wang L.

Hum Pathol. 2016 Nov;57:176-181. doi: 10.1016/j.humpath.2016.07.017. Epub 2016 Aug 3.

PMID:
27498063
20.

Can Sentinel Lymph Node Biopsy Be Spared in Papillary Carcinoma of the Breast?

Wang Y, Lu S, Graves T, Ouseph MM, Resnick MB, Yakirevich E.

Clin Breast Cancer. 2017 Apr;17(2):127-133. doi: 10.1016/j.clbc.2016.08.009. Epub 2016 Sep 8.

PMID:
27692774
21.

Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway.

Wood SM, Gill AJ, Brodsky AS, Lu S, Friedman K, Karashchuk G, Lombardo K, Yang D, Resnick MB.

Mod Pathol. 2017 Jan;30(1):123-133. doi: 10.1038/modpathol.2016.170. Epub 2016 Sep 30.

22.

Identification of stromal ColXα1 and tumor-infiltrating lymphocytes as putative predictive markers of neoadjuvant therapy in estrogen receptor-positive/HER2-positive breast cancer.

Brodsky AS, Xiong J, Yang D, Schorl C, Fenton MA, Graves TA, Sikov WM, Resnick MB, Wang Y.

BMC Cancer. 2016 Apr 18;16:274. doi: 10.1186/s12885-016-2302-5.

23.

Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment.

Friedman K, Brodsky AS, Lu S, Wood S, Gill AJ, Lombardo K, Yang D, Resnick MB.

Mod Pathol. 2016 May;29(5):528-41. doi: 10.1038/modpathol.2016.54. Epub 2016 Mar 11.

24.

Oncogenic ALK Fusion in Rare and Aggressive Subtype of Colorectal Adenocarcinoma as a Potential Therapeutic Target.

Yakirevich E, Resnick MB, Mangray S, Wheeler M, Jackson CL, Lombardo KA, Lee J, Kim KM, Gill AJ, Wang K, Gowen K, Sun J, Miller VA, Stephens PJ, Ali SM, Ross JS, Safran H.

Clin Cancer Res. 2016 Aug 1;22(15):3831-40. doi: 10.1158/1078-0432.CCR-15-3000. Epub 2016 Mar 1.

25.
26.

Advances in the Molecular Profiling of Tumor Tissue.

Resnick MB, Perez K.

R I Med J (2013). 2015 Oct 1;98(10):15. No abstract available.

PMID:
26422539
27.

Mucinous cystic neoplasm of the pancreas with increased IgG4+ plasma cells and histopathologic features of autoimmune pancreatitis/IgG4-related disease.

Yakirevich E, Henriksen KJ, Miner T, Resnick MB.

Pancreas. 2015 May;44(4):674-6. doi: 10.1097/MPA.0000000000000296. No abstract available.

PMID:
25872133
28.

Cadherin 17 is a sensitive and specific marker for metanephric adenoma.

Yakirevich E, Magi-Galluzzi C, Grada Z, Lu S, Resnick MB, Mangray S.

Am J Surg Pathol. 2015 Apr;39(4):479-86. doi: 10.1097/PAS.0000000000000401.

29.

A Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling.

Yakirevich E, Ali SM, Mega A, McMahon C, Brodsky AS, Ross JS, Allen J, Elvin JA, Safran H, Resnick MB.

Am J Surg Pathol. 2015 Jun;39(6):858-63. doi: 10.1097/PAS.0000000000000403.

PMID:
25724004
30.

Immunohistochemical analysis of eosinophilic esophagitis.

Matoso A, Resnick MB.

Clin Gastroenterol Hepatol. 2015 Jun;13(6):1209-10. doi: 10.1016/j.cgh.2014.12.024. Epub 2015 Jan 3. No abstract available.

PMID:
25562797
31.

Expression of cadherin 17 in well-differentiated neuroendocrine tumours.

Snow AN, Mangray S, Lu S, Clubwala R, Li J, Resnick MB, Yakirevich E.

Histopathology. 2015 Jun;66(7):1010-21. doi: 10.1111/his.12610. Epub 2015 Jan 13.

PMID:
25388236
32.

Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors.

Ellermeier C, Vang S, Cleveland K, Durand W, Resnick MB, Brodsky AS.

Anticancer Res. 2014 Aug;34(8):3957-67.

PMID:
25075017
33.

Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter study.

Sargent DJ, Shi Q, Gill S, Louvet C, Everson RB, Kellner U, Clancy TE, Pipas JM, Resnick MB, Meyers MO, Wu TT, Huntsman D, Validire P, Farooq U, Pavey ES, Beaudry G, Haince JF, Fradet Y.

Clin Cancer Res. 2014 Aug 15;20(16):4361-9. doi: 10.1158/1078-0432.CCR-13-2659. Epub 2014 Jun 11.

34.

Correlation of ALOX15 expression with eosinophilic or reflux esophagitis in a cohort of pediatric patients with esophageal eosinophilia.

Matoso A, Allen D, Herzlinger M, Ferreira J, Chen S, Lu S, Fabre V, Monahan R, Yang D, Noble L, Mangray S, Resnick MB.

Hum Pathol. 2014 Jun;45(6):1205-12. doi: 10.1016/j.humpath.2014.01.021. Epub 2014 Feb 6.

PMID:
24742828
35.

Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells.

Tang X, Zheng D, Hu P, Zeng Z, Li M, Tucker L, Monahan R, Resnick MB, Liu M, Ramratnam B.

Nucleic Acids Res. 2014 Mar;42(5):2988-98. doi: 10.1093/nar/gkt1275. Epub 2013 Dec 13.

36.

Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.

Taliano RJ, Lu S, Singh K, Mangray S, Tavares R, Noble L, Resnick MB, Yakirevich E.

Hum Pathol. 2013 Dec;44(12):2743-50. doi: 10.1016/j.humpath.2013.07.021.

37.

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients.

Cross-Knorr S, Lu S, Perez K, Guevara S, Brilliant K, Pisano C, Quesenberry PJ, Resnick MB, Chatterjee D.

BMC Cancer. 2013 Oct 8;13:463. doi: 10.1186/1471-2407-13-463.

38.

Pathology of gastric cancer and its precursor lesions.

Yakirevich E, Resnick MB.

Gastroenterol Clin North Am. 2013 Jun;42(2):261-84. doi: 10.1016/j.gtc.2013.01.004. Epub 2013 Mar 1. Review.

PMID:
23639640
39.

Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis.

Matoso A, Mukkada VA, Lu S, Monahan R, Cleveland K, Noble L, Mangray S, Resnick MB.

Mod Pathol. 2013 May;26(5):665-76. doi: 10.1038/modpathol.2013.41. Epub 2013 Mar 15.

40.

NADPH oxidase NOX5-S and nuclear factor κB1 mediate acid-induced microsomal prostaglandin E synthase-1 expression in Barrett's esophageal adenocarcinoma cells.

Zhou X, Li D, Resnick MB, Wands J, Cao W.

Mol Pharmacol. 2013 May;83(5):978-90. doi: 10.1124/mol.112.083287. Epub 2013 Feb 25.

41.

Expression of bile acid receptor TGR5 in gastric adenocarcinoma.

Cao W, Tian W, Hong J, Li D, Tavares R, Noble L, Moss SF, Resnick MB.

Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G322-7. doi: 10.1152/ajpgi.00263.2012. Epub 2012 Dec 13.

42.

Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype.

Lu S, Singh K, Mangray S, Tavares R, Noble L, Resnick MB, Yakirevich E.

Mod Pathol. 2013 Apr;26(4):485-95. doi: 10.1038/modpathol.2012.187. Epub 2012 Dec 7.

43.

Immunohistochemistry of colorectal carcinoma: current practice and evolving applications.

Taliano RJ, LeGolvan M, Resnick MB.

Hum Pathol. 2013 Feb;44(2):151-63. doi: 10.1016/j.humpath.2012.04.017. Epub 2012 Aug 29. Review.

PMID:
22939578
44.

MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets.

Lu S, Mukkada VA, Mangray S, Cleveland K, Shillingford N, Schorl C, Brodsky AS, Resnick MB.

PLoS One. 2012;7(7):e40676. doi: 10.1371/journal.pone.0040676. Epub 2012 Jul 16.

45.

Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach.

Legolvan MP, Taliano RJ, Resnick MB.

Hum Pathol. 2012 Aug;43(8):1157-68. doi: 10.1016/j.humpath.2012.03.003. Epub 2012 Jun 1. Review.

PMID:
22658275
46.

MR enterography correlates highly with colonoscopy and histology for both distal ileal and colonic Crohn's disease in 310 patients.

Grand DJ, Kampalath V, Harris A, Patel A, Resnick MB, Machan J, Beland M, Chen WT, Shah SA.

Eur J Radiol. 2012 May;81(5):e763-9. doi: 10.1016/j.ejrad.2012.02.011. Epub 2012 Mar 23.

PMID:
22445795
47.

VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.

O'Connell JT, Sugimoto H, Cooke VG, MacDonald BA, Mehta AI, LeBleu VS, Dewar R, Rocha RM, Brentani RR, Resnick MB, Neilson EG, Zeisberg M, Kalluri R.

Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16002-7. doi: 10.1073/pnas.1109493108. Epub 2011 Sep 12.

48.

Promotion of cytoplasmic mislocalization of p27 by Helicobacter pylori in gastric cancer.

Wen S, So Y, Singh K, Slingerland JM, Resnick MB, Zhang S, Ruiz V, Moss SF.

Oncogene. 2012 Apr 5;31(14):1771-80. doi: 10.1038/onc.2011.362. Epub 2011 Aug 15.

49.

LCM assisted biomarker discovery from archival neoplastic gastrointestinal tissues.

Meitner PA, Resnick MB.

Methods Mol Biol. 2011;755:165-80. doi: 10.1007/978-1-61779-163-5_13.

PMID:
21761302
50.

Signaling in H2O2-induced increase in cell proliferation in Barrett's esophageal adenocarcinoma cells.

Zhou X, Li D, Resnick MB, Behar J, Wands J, Cao W.

J Pharmacol Exp Ther. 2011 Oct;339(1):218-27. doi: 10.1124/jpet.111.182352. Epub 2011 Jul 12.

Supplemental Content

Loading ...
Support Center